23Mar 2023
Cholesterol Meds and Dry Eye: What You Need to Know from a Large-Scale Case-Control Study

Cholesterol Meds and Dry Eye: What You Need to Know from a Large-Scale Case-Control Study

This study aimed to evaluate the association between lipid-lowering agent use and the risk of diagnosed dry eye disease (DED). The retrospective case-control study included 780,786 patients who received lipid-lowering agents from 2002 to 2016, with 17,409 newly diagnosed with DED during a follow-up period of two years or more. Statin users had a significantly higher risk of DED than non-users, while fibrate users did not show a higher risk. However, the type, duration, and intensity of statin use were not significantly associated with DED risks. Further studies are needed to identify relevant factors related to DED risks with a statin.

  • #ophthalmology

Like

Save

Share